Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
Neurotech International (NTI) has flagged to its shareholders that the FDA hasn't granted its product NTI164 orphan drug status.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
JAG | Ann: Ceasing to be a substantial holder | 22/08/13 | 0 | 745 | |||
|
|||||||
JAG | Ann: Change of Director's Interest Notice | 22/08/13 | 0 | 639 | |||
|
|||||||
JAG | Ann: Initial & Final Director's Interest Noti | 22/08/13 | 0 | 627 | |||
|
|||||||
JAG | Ann: Settlement of Acquisition and Completion of | 21/08/13 | 1 | 1.0K | |||
|
|||||||
JAG | Ann: Appendix 3B | 20/08/13 | 0 | 714 | |||
|
|||||||
JAG | Ann: Appendix 3B and Section 708A95)(e) | 20/08/13 | 0 | 589 | |||
|
|||||||
JAG | richard monti on the board of fmg ??? | 16/08/13 | 6 | 3.1K | |||
|
|||||||
JAG | Ann: Competent Persons Statement | 08/08/13 | 0 | 526 | |||
|
See All Discussions